Cite

HARVARD Citation

    Panoutsopoulou, K. et al. (2020). MiR‐181a overexpression predicts the poor treatment response and early‐progression of serous ovarian cancer patients. International journal of cancer. 147 (12), pp. 3560-3573. [Online]. 
  
Back to record